The COVID-19 crisis changed the way people work across industries including the pharma industry. MD Analytics teamed up with the professional association for women in the pharma industry Women Leaders in Pharma to conduct a study on the impact on of COVID-19 on women who work in the pharma industry.
Current recommendations of CAM therapies and interventions are strong among Canadian GPs within key therapeutic areas, and are expected to grow moving forward. 88% of GPs polled have recommended a CAM therapy at least once in the past six months for the treatment of pain, anxiety and stress, high blood pressure, depression, ADHD or IBS.
By the end of 2018, 3 in 5 GPs expect massage therapy, yoga, acupuncture, and meditation to be accepted as viable CAM options among the conventional medical community. By acknowledging that CAM therapies can be a useful complement to pharmaceutical solutions, the pharma industry has an opportunity to build on their current messaging with existing customers, and potentially create a new channel for brand recommendations among CAM therapists. They key will be taking the initiative to educate CAM therapists and their patients on how to best incorporate the two approaches (e.g. massage therapy alongside our product is strongly recommended). See our infographic for a more detailed look at the findings from this survey.
Past Quick Polls
The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.
Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
The COVID-19 crisis has significantly impacted physicians’ practices; but how and to what extent? Physicians have been managing significant workloads, while learning on the fly how to navigate and setup virtual meetings. Maintaining high levels of patient care while minimizing in-person interactions has also been challenging.